BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7753052)

  • 1. Truncated MHC class II cytoplasmic and transmembrane domains: effect on plasma membrane expression.
    Wade WF; Khrebtukova I; Schreiber KL; McKean DJ; Wade TK
    Mol Immunol; 1995 Apr; 32(6):433-46. PubMed ID: 7753052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
    J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of murine MHC class II molecule expression. Identification of A beta residues responsible for allele-specific cell surface expression.
    Buerstedde JM; Pease LR; Nilson AE; Bell MP; Chase C; Buerstedde G; McKean DJ
    J Exp Med; 1988 Sep; 168(3):823-37. PubMed ID: 3049906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
    Busch R; Vturina IY; Drexler J; Momburg F; Hämmerling GJ
    Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains.
    Rich T; Lawler SE; Lord JM; Blancheteau VM; Charron DJ; Mooney NA
    J Immunol; 1997 Oct; 159(8):3792-8. PubMed ID: 9378966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational diffusion of class II major histocompatibility complex molecules is constrained by their cytoplasmic domains.
    Wade WF; Freed JH; Edidin M
    J Cell Biol; 1989 Dec; 109(6 Pt 2):3325-31. PubMed ID: 2557353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.
    Dolan BP; Phelan TP; Ilkovitch D; Qi L; Wade WF; Laufer TM; Ostrand-Rosenberg S
    J Immunol; 2004 Jan; 172(2):907-14. PubMed ID: 14707062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a truncated invariant chain on in vitro assembly of class II MHC molecules depends on the affinity of invariant chain for a given alpha beta dimer.
    Han R
    Immunol Invest; 1997 Jun; 26(4):421-37. PubMed ID: 9246563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.
    Smiley ST; Rudensky AY; Glimcher LH; Grusby MJ
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):241-4. PubMed ID: 8552613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional effects of N-linked oligosaccharides located on the external domain of murine class II molecules.
    Wei BY; Buerstedde JM; Bell M; Chase C; Nilson A; Browne A; Pease L; McKean DJ
    J Immunol; 1991 Apr; 146(7):2358-66. PubMed ID: 1706396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence.
    Arneson LS; Miller J
    J Cell Biol; 1995 Jun; 129(5):1217-28. PubMed ID: 7775569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered I-A protein-mediated transmembrane signaling in B cells that express truncated I-Ak protein.
    Wade WF; Chen ZZ; Maki R; McKercher S; Palmer E; Cambier JC; Freed JH
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6297-301. PubMed ID: 2503831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of invariant chain (Ii)-calnexin interaction results in enhanced degradation of Ii but does not prevent the assembly of alpha beta Ii complexes.
    Romagnoli P; Germain RN
    J Exp Med; 1995 Dec; 182(6):2027-36. PubMed ID: 7500048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex alpha/beta chains.
    Sant AJ; Hendrix LR; Coligan JE; Maloy WL; Germain RN
    J Exp Med; 1991 Oct; 174(4):799-808. PubMed ID: 1919435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment.
    Layet C; Germain RN
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2346-50. PubMed ID: 1900941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments.
    Warmerdam PA; Long EO; Roche PA
    J Cell Biol; 1996 Apr; 133(2):281-91. PubMed ID: 8609162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II molecules that lack cytoplasmic domains are associated with the cytoskeleton.
    Chia CP; Khrebtukova I; McCluskey J; Wade WF
    J Immunol; 1994 Oct; 153(8):3398-407. PubMed ID: 7930565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of class II alpha chain polymorphic residues defines location of A alpha k serologic epitopes and alters association between alpha beta and Ii polypeptides.
    Wei BY; Schreiber K; Buerstedde JM; Bell M; Nilson A; Huntoon C; Chase C; McKean DJ
    Int Immunol; 1994 Feb; 6(2):297-305. PubMed ID: 7512376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling.
    Harton JA; Bishop GA
    J Immunol; 1993 Nov; 151(10):5282-9. PubMed ID: 8228224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
    Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
    J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.